Filing Flows › Comparisons › GLUE vs AUTL
Monte Rosa Therapeutics vs Autolus Therapeutics: GLUE and AUTL compared
Monte Rosa Therapeutics is the larger company: $54.4M of revenue in its latest quarter (Q3 2026) against $45.7M for Autolus Therapeutics (Q2 2026). Monte Rosa Therapeutics is growing faster (+326% against +118% a year earlier). Monte Rosa Therapeutics is more profitable, with an operating margin of -3.6% against -95.9%.
Where the money goes: GLUE and AUTL
Monte Rosa Therapeutics (GLUE) · Q3 2026
Monte Rosa Therapeutics, Q3 2026: revenue $54.4M (+326% year over year), operating margin -3.6%, net earnings $3.1M, operating cash flow −$41.0M. The chart follows the revenue to costs, profit and cash.
Autolus Therapeutics (AUTL) · Q2 2026
Autolus Therapeutics, Q2 2026: revenue $45.7M (+118% year over year), operating margin -95.9%, net loss $39.1M, operating cash flow −$25.1M. The chart follows the revenue to costs, profit and cash.
| Monte Rosa Therapeutics (GLUE) | Autolus Therapeutics (AUTL) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $54.4M | $45.7M |
| Revenue growth, Y/Y | +326% | +118% |
| Operating margin | -3.6% | -95.9% |
| Net earnings | $3.1M | −$39.1M |
| Net margin | 5.6% | -85.6% |
| Operating cash flow | −$41.0M | −$25.1M |
Where the revenue comes from
Autolus Therapeutics
- Product revenue, net: $45.7M (100%)
- License revenue: $17K (0%)
Questions
Which is bigger, Monte Rosa Therapeutics or Autolus Therapeutics?
Monte Rosa Therapeutics is the larger company: $54.4M of revenue in its latest quarter (Q3 2026) against $45.7M for Autolus Therapeutics (Q2 2026).
Is Monte Rosa Therapeutics or Autolus Therapeutics growing faster?
Monte Rosa Therapeutics is growing faster (+326% against +118% a year earlier).
Which is more profitable, Monte Rosa Therapeutics or Autolus Therapeutics?
Monte Rosa Therapeutics is more profitable, with an operating margin of -3.6% against -95.9%.
More: Monte Rosa Therapeutics earnings · how Monte Rosa Therapeutics makes money · Autolus Therapeutics earnings · how Autolus Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.